The development of copper radiopharmaceuticals for imaging and therapy

Keyphrases

• Chemical Structure 100%
• Radionuclides 100%
• Radiopharmaceuticals 100%
• Radiotracer 100%
• Copper Radionuclides 100%
• Copper Radiopharmaceuticals 100%
• Positron Emission Tomography 50%
• Biological Processes 50%
• Nanoparticles 50%
• High Specificity 50%
• Radiometals 50%
• Clinical Setting 50%
• Targeted Agents 50%
• Short Half-life 50%
• PET Tracer 50%
• Small Organic Molecules 50%
• In Vivo Properties 50%
• Biological Phenomena 50%
• Pharmacokinetics in Vivo 50%
• Fluorine-18 50%
• Chelates 50%
• Factor Importance 50%
• Carbon-11 50%
• Continuing Development 50%
• Copper-based 50%
• Biological Half-life 50%
• Life Cycle Energy 50%
• System Perturbation 50%
• Coordination Chemistry 50%
• Decay Energy 50%
• Chemical Linker 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Radioisotope 100%
• Radiopharmaceutical Agent 100%
• Tracer 75%
• Nanoparticle 25%
• Carbon 11 25%
• Chelate 25%
• Fluorine 18 25%
• Biological Half-Life 25%
• Polyethylene Terephthalate 25%
• Pharmacokinetics 25%